ArticleIndoor air2021
Effective design of barrier enclosure to contain aerosol emissions from COVID-19 patients.
Article in Indoor air, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 18 citations in OpenAlex.
- A Portable, Foldable Negative-Pressure Aerosol-Containment System (FNPACS) for Aerosol Control During Aerosol-Generating Procedures.Bioengineering (Basel, Switzerland) · 2026Article
- An Individual Barrier Enclosure Actively Removing Aerosols for Airborne Isolation: A Vacuum Tent.Respiratory care · 2024Article
- Assessment of aerosol persistence in ICUs via low-cost sensor network and zonal models.Scientific reports · 2023Article
- SARS-CoV-2 in wastewater: From detection to evaluation.Materials today. Advances · 2022Review
- Polylactic acid face masks: Are these the sustainable solutions in times of COVID-19 pandemic?The Science of the total environment · 2022Article
- Article
- Airborne SARS-CoV-2 surveillance in hospital environment using high-flowrate air samplers and its comparison to surface sampling.Indoor air · 2022Article
- Design and development of multilayer cotton masks via machine learning.Materials today. Advances · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 5 institutions in 1 country.
Funding
Abstract
Facing shortages of personal protective equipment, some clinicians have advocated the use of barrier enclosures (typically mounted over the head, with and without suction) to contain aerosol emissions from coronavirus disease 2019 (COVID-19) patients. There is, however, little evidence for its usefulness. To test the effectiveness of such a device, we built a manikin that can expire micron-sized aerosols at flow rates close to physiological conditions. We then placed the manikin inside the enclosure and used a laser sheet to visualize the aerosol leaking out. We show that with sufficient suction, it is possible to effectively contain aerosol from the manikin, reducing aerosol exposure outside the enclosure by 99%. In contrast, a passive barrier without suction only reduces aerosol exposure by 60%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.